Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)
10.52
+0.23
(+2.22%)
Streaming Delayed Price
Updated: 12:03 PM EDT, Sep 11, 2025
Add to My Watchlist
Press Releases about Ginkgo Bioworks Holdings, Inc. Class A Common Stock
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
September 04, 2025
From Ginkgo Bioworks
Via Business Wire
![]() From bit.bio
Via Business Wire
![]() ![]() ![]() ![]()
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
February 28, 2023
From Cronos Group Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]()
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
April 05, 2022
Via Business Wire
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|